Methadone appears safe and effective in treating people who use fentanyl, suggests a study presented at the recent annual meeting of the American Society of Addiction Medicine.
A new study finds there are no significant differences between young adults who misuse prescription opioids and those who inject heroin, except for the amount of time they have used drugs.
The Food and Drug Administration will allow drug companies to sell medications that reduce opioid cravings, even if they do not fully stop addiction, The New York Times reports.
Researchers at New York University are studying whether providing the opioid-addiction medicine extended-release naltrexone (Vivitrol) to individuals when they leave jail reduces their risk of relapse and overdose.
Nurse practitioners and physician assistants will now be eligible to prescribe and dispense the opioid addiction treatment buprenorphine from their office, Reuters reports.
A new study will assess whether starting medication-assisted treatment in the emergency room within hours of an opioid overdose will prevent people from relapsing after they recover.
The Food and Drug Administration has approved the first ever buprenorphine injection for the treatment of moderate-to-severe opioid use disorder in adult patients.
The Food and Drug Administration will encourage widespread use of medication-assisted treatment for opioid addiction, the agency’s commissioner said Wednesday.
The Food and Drug Administration issued a new warning this week about mixing medication to treat opioid addiction with anti-anxiety drugs. Both types of drugs slow breathing and brain activity.
Some insurance companies are restricting patients’ access to pain medicines with a lower risk of dependence or addiction, while making it easier to get generic opioid drugs, The New York Times reports.
Authorities planning for natural disasters such as hurricanes must prepare for its effect on people struggling with drugs or alcohol, experts tell the Associated Press. The stress of hurricanes leads to an increased danger of relapse and overdose.
While medication-assisted treatment is the recommended therapy for pregnant women addicted to opioids, medically supervised withdrawal is an option if a woman does not accept treatment, the American College of Obstetricians and Gynecologists said this week.
A new report finds spending on Medicaid-covered prescriptions for the treatment of opioid use disorder and opioid overdose increased dramatically between 2011 and 2016, according to NPR. The largest increase occurred after 2014.
The number of people covered by the health insurer Blue Cross Blue Shield who were diagnosed with an opioid addiction rose almost 500 percent from 2010 to 2016.
Health and Human Services Secretary Tom Price’s description of medication-assisted treatment for addiction as "substituting one opioid for another" is inaccurate, according to addiction experts who have asked Price to “set the record straight.”
The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
Aetna is the latest health insurer to announce it will no longer require preauthorization for opioid addiction treatment, Kaiser Health News reports. The change takes effect this month and applies to commercial plans.
The discovery of a gene variant associated with opioid addiction in African Americans may lead to personalized methadone treatment, according to HealthDay.
This website uses cookies. We use cookies and similar technologies to give
you the best experience. By using this website, you accept our Privacy Policy and Terms of Use.
Get Support
